RS Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | $504K | Hold |
11,090
| – | – | 0.01% | 342 |
|
|
2016
Q1 | $439K | Sell |
11,090
-598,860
| -98% | -$23.7M | ﹤0.01% | 339 |
|
|
2015
Q4 | $34.5M | Sell |
609,950
-229,010
| -27% | -$13M | 0.31% | 111 |
|
|
2015
Q3 | $33.4M | Buy |
838,960
+127,950
| +18% | +$5.09M | 0.3% | 120 |
|
|
2015
Q2 | $34M | Buy |
711,010
+114,130
| +19% | +$5.45M | 0.29% | 134 |
|
|
2015
Q1 | $23.7M | Buy |
+596,880
| New | +$23.7M | 0.21% | 169 |
|